Skip to content

Integrating Network Pharmacology and Molecular Docking to Uncover Neuroprotective Phytochemicals From Symplocos racemosa Roxb. in Mitigating Alzheimer's Disease

Sep 2026 · ChemistrySelect · 0 citations · 46 references

TL;DR

Findings position SRR as a hypothesis‐generating source of multi‐target candidate molecules and provide a prioritized framework for experimental validation in AD.

Abstract

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by complex pathological mechanisms that limit the efficacy of conventional single‐target therapies. This study aimed to systematically explore the neuroprotective potential of phytoconstituents from Symplocos racemosa Roxb. (SRR) using an integrated computational approach combining network pharmacology, ADMET profiling, toxicity prediction, pathway enrichment, and molecular docking. Four bioactive compounds, oleanolic acid, betulinic acid, 19α‐hydroxyasiatic acid, and β‐sitosterol, were identified based on drug‐likeness and pharmacokinetic criteria. These compounds generally showed favorable pharmacokinetic profiles, although some deviations from Lipinski's criteria were observed. Network pharmacology analysis revealed 142 overlapping targets between SRR and AD, indicating a multi‐target therapeutic potential. Protein–protein interaction analysis identified major hub genes, including TNF, IL6, MAPK3, ESR‐1, and PPARγ, which are implicated in neuroinflammation, oxidative stress, apoptosis, and metabolic dysfunction. Functional enrichment analyses demonstrated significant involvement of these targets in key biological pathways, including inflammatory signaling, steroid hormone response, and IL17, TNF, and C‐type lectin receptor signaling pathways. Molecular docking provided structural support for plausible interactions between the selected compounds and core targets, particularly TNF, IL6, and MAPK3. These findings position SRR as a hypothesis‐generating source of multi‐target candidate molecules and provide a prioritized framework for experimental validation in AD.

View source

Similar papers

Open access Aug 2026

INTEGRATED NETWORK PHARMACOLOGY, MOLECULAR DOCKING, AND IN-VITRO VALIDATION REVEAL POTENTIAL NOOTROPIC PHYTOCONSTITUENTS FROM SELECTED INDIAN MEDICINAL PLANTS AGAINST COGNITIVE IMPAIRMENT

Evaluated phytoconstituents from Allium cepa, Curcuma longa, and Coleus forskohlii suggest that curcumin, quercetin, and rosmarinic acid are promising multi-target nootropic phytoconstituents with therapeutic potential for the treatment of cognitive impairment.

M. Manke, O. Bhusnure · 0 citations
Open access Aug 2026

Integrative network pharmacology and molecular modeling approaches reveal the therapeutic potential of Syzygium samarangense phytocompounds against diabetes retinopathy

These multi-target interactions suggest that S. samarangense phytochemicals can modulate key DR-associated pathways, and exhibits promising multi-target activity against Diabetes retinopathy.

Arun Kandhan, B. Mathew, Sundarrajan Thirugnanasambandam · 0 citations
Open access Sep 2026

Elucidating the multitarget therapeutic potential of Camellia sinensis (Tea) phytochemicals using network pharmacology, functional annotation, and molecular docking

Findings provide mechanistic insights into the multi-target pharmacological potential of C. sinensis phytochemicals and highlight their prospective therapeutic relevance against cancer, metabolic, inflammatory, and neurodegenerative disorders.

Md. Mainuddin Hossain · 0 citations
Aug 2026

In Silico Multitarget Profiling of Betulinic Acid: ADME/Protox-II Toxicity, Network Pharmacology, and Molecular Docking for Diabetic Osteoporosis.

BA is a secure multi-target treatment option for DO, providing molecular insights for forthcoming experimental validation and multi-target interactions of BA, especially with key signaling pathways, indicate a broad involvement in the metabolic and inflammatory processes contributing to the development of DO.

Sheenam Sharma, Rishabh Chaudhary, Chirag Sharma et al. · 0 citations
Open access Sep 2026

Network Pharmacology-Guided Identification of Orientin from Passiflora incarnata Reveals Neuroprotective Effects Against Glutamate-Induced Excitotoxicity Through Regulation of Calcium Homeostasis

The utility of network pharmacology-guided prioritization for identifying bioactive constituents of P. incarnata and support orientin as a neuroprotective candidate for further mechanistic and in vivo investigation are demonstrated.

Jinyoung Park, Muhammad Yasir, Eun-Taek Han et al. · 0 citations
Open access Sep 2026

Comparative Network Pharmacology and Molecular Docking Analysis of Ursodeoxycholic Acid and Tauroursodeoxycholic Acid in Alzheimer’s Disease-Associated Molecular Networks

Results from approaches examining systems and structure both indicate that ursodeoxycholic acid and tauroursodeoxycholic acid show profiles of action that work together, but they should not be interpreted as direct evidence of therapeutic efficacy in Alzheimer’s disease.

Bo Zhou, Yu Zhong, Xin Meng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.